NXGL NEXGEL INC

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Gurenlian and his training camp to use NEXGEL’s Turfguard for turf burn in lacrosse

LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today it has partnered with former Major League Lacrosse (MLL) player and founder of The Face-off Academy, Greg “The Beast” Gurenlian, to provide athletes with a better treatment for turf burn through the use of NEXGEL’s Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds.

Adam Levy, CEO of NEXGEL, said, “We are thrilled to partner with Greg and his team to address the harmful effects of turf burn including, pain, infection and long-term scarring. We look forward to working with Greg and supporting him and other athletes on and off the field with Turfguard for topical recovery. NEXGEL aims to help all athletes through our gentle skin patches for treatment and protection.”

“I’ve been playing lacrosse for over 20 years and have had more than my fair share of turf burn,” said Greg Gurenlian, Founder of The Face-off Academy. “As a faceoff man, we are constantly taking a beating on our feet and off of it. I don’t know a single athlete that hasn’t dealt with turf burn at some point in their careers. The pain is one thing but dealing with the infections and long-term scarring is a huge concern. Turfguard is a medical grade response to these burns.”

Turfguard’s FDA cleared patches maintain a moist wound environment and aid in removing non-viable tissues from the wound. The patches do not pull on delicate, new or healing skin and provide an instant cooling relief to the affected area. Manufactured out of the Company’s facility in Langhorne, Pa., Turfguard is available for purchase on .

Greg Gurenlian is a former professional field lacrosse player from Springfield, Pennsylvania. During his lacrosse career, Gurenlian was a 6x Professional Lacrosse All-Pro, a member of the 2018 Team USA Gold Medal team and holds the U.S. record for faceoff percentage in a world game (81%). He also won the MLL MVP and the Steinfeld Trophy for winning the 2015 MLL Championship. Gurenlian retired as a member of Redwoods Lacrosse Club of the Premier Lacrosse League. He is also the founder of The Face-off Academy, a place where young players are trained in faceoffs.

Mr. Gurenlian added, “Used in hospitals for years, this is exactly what every trainer, coach and athlete needs to sooth, heal and stop infection. I’m proud to team up with Turfguard and am grateful that we could work together with Wilson Management Alliance to make this partnership happen. Lacrosse players around the country will now get a chance to see how incredibly effective Turfguard is.”

About NEXGEL, INC.

NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

Forward-Looking Statement

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "confidence," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs, such as "will," "should," "would," "may," and "could," are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise, except as required by law. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2021, including but not limited to the discussion under "Risk Factors" therein, which the Company filed with the SEC and which may be viewed at .

Investor Contact:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254

Media Contacts:

Kelly Knobeck

Director of Consumer Products

###



EN
07/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEXGEL INC

 PRESS RELEASE

NEXGEL Reports Second Quarter 2025 Financial Results

NEXGEL Reports Second Quarter 2025 Financial Results Second quarter 2025 revenue totaled $2.88 million, an increase of 100.3% as compared to $1.44 million for the same period year-over-year Gross Profit for the quarter was 43.6%, compared to 20.3% for the same period in 2024 Company is reiterating revenue guidance for 2025 of $13 million and to achieve positive EBITDA during the year LANGHORNE, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-ge...

 PRESS RELEASE

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the second quarter 2025, after the market close on August 12, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET ...

 PRESS RELEASE

NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardi...

NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors LANGHORNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced the appointment of Steve Ciardiello, CPA, to its Board of Directors. With more than 25 years of experience as a senior finance executive and current Chief Accounting Officer of Shutterstock, Inc. (NYSE:...

 PRESS RELEASE

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Pr...

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement LANGHORNE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it has entered into definitive agreements for the issuance and sale of an aggregate of 413,044 shares of its common stock (the “Shares”) at $2.30 a share. In a concurrent private placement, NEXGEL also agreed to issue to th...

 PRESS RELEASE

NEXGEL and STADA AG Announce Expansion of Partnership for North Americ...

NEXGEL and STADA AG Announce Expansion of Partnership for North America LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its partnership with (“STADA”), a European leader in consumer health. The expansion includes the planned launch of digestive enzyme formulas and solutions targeting scars and stretch marks. As part of the agreement, STADA will advance $1 million to NEXGEL in non-dilutive...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch